Evidence map›Paper›PMID 30441761›Full record

ReviewNutrients2018

Sulforaphane from Cruciferous Vegetables: Recent Advances to Improve Glioblastoma Treatment.

Giulia Sita, Patrizia Hrelia, Agnese Graziosi, Fabiana Morroni

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Rapha MyrInternational journal of molecular sciences · 2020
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giulia SitaDepartment of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. giulia.sita2@unibo.it.ORCID 0000-0001-6627-7078
Patrizia HreliaDepartment of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. patrizia.hrelia@unibo.it.ORCID 0000-0002-8415-3711
Agnese GraziosiDepartment of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. agnese.graziosi2@unibo.it.ORCID 0000-0002-4992-7902
Fabiana MorroniDepartment of Pharmacy and BioTechnology, Alma Mater Studiorum-University of Bologna, via Irnerio 48, 40126 Bologna, Italy. fabiana.morroni@unibo.it.ORCID 0000-0001-6494-5968
University of Bologna · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca 20152HKF3Z
6 · The paper itself

Abstract

Sulforaphane (SFN), an isothiocyanate (ITC) derived from cruciferous vegetables, particularly broccoli and broccoli sprouts, has been widely investigated due to its promising health-promoting properties in disease, and low toxicity in normal tissue. Although not yet fully understood, many mechanisms of anticancer activity at each step of cancer development have been attributed to this ITC. Given the promising data available regarding SFN, this review aimed to provide an overview on the potential activities of SFN related to the cellular mechanisms involved in glioblastoma (GBM) progression. GBM is the most frequent malignant brain tumor among adults and is currently an incurable disease due mostly to its highly invasive phenotype, and the poor efficacy of the available therapies. Despite all efforts, the median overall survival of GBM patients remains approximately 1.5 years under therapy. Therefore, there is an urgent need to provide support for translating the progress in understanding the molecular background of GBM into more complex, but promising therapeutic strategies, in which SFN may find a leading role.

Indexed as

Antineoplastic Agents, PhytogenicBrassicaGlioblastomaHumansIsothiocyanatesSulfoxidesVegetablesAntineoplastic Agents, PhytogenicIsothiocyanatessulforaphaneSulfoxidesapoptosischemopreventionglioblastoma multiformesulforaphane

Identifiers

PMID30441761
PMCPMC6267435
OpenAlexW2901358668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.